AstraZeneca NFX deal ?12 Mar 2026 08:51
From LTbekiever
Did anyone notice that they also got ODD designation on the same day as NFX? See below,
small molecule inhibitor of ARG-1 and ARG-2
Date Designated: 03/09/2026
Orphan Designation: treatment of idiopathic pulmonary fibrosis
Sponsor: AstraZeneca Pharmaceuticals LP